Daily FNArena News

As big capital’s focus homes in on modern slavery, Monash University has taken steps to rank the ASX300 on disclosure, applying an A-F performance rating, perhaps providing early insights into ESG winners and losers

Funds underperformance this year has led to Magellan Financial Group losing its biggest client, and brokers suspect this is just the beginning

A glance through the latest expert views and predictions about commodities: zinc & rare earths

Analysts believe ReadyTech’s acquisition last week of cloud-based contract management and procurement software provider Open Windows Software was struck on a good price and represents a good strategic fit

While the additional costs incurred by Transurban Group on the Westgate Tunnel Project are higher than anticipated, brokers are relieved court action was avoided and now focus upon a steady improvement in traffic numbers

Michael Gable of Fairmont Equities suggests that on the positive side, 7200 appears to be support for the ASX200, but a break would be negative

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Brambles from Morningstar

Its latest acquisition has increased Ramsay Health Care’s exposure to the high growth mental health care segment, but potential opportunity has largely failed to impress analysts

FNArena has received a number of enquiries as to why the big CSL share price fall yesterday. For the less experienced, here is the explanation

Brokers were caught out by the extent of covid ramifications to date in the first half and the level of cost increases hitting Woolworths’ bottom line. But there is some light at the end of the aisle